Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma

被引:17
作者
Azad, Arun [1 ]
Herbertson, Rebecca A. [2 ]
Pook, David [2 ]
White, Shane [1 ]
Mitchell, Paul L. R. [1 ]
Tebbutt, Niall C. [1 ,2 ]
机构
[1] Austin Hlth, Dept Med Oncol, Heidelberg, Vic, Australia
[2] Austin Hlth, Ludwig Inst Canc Res, Heidelberg, Vic, Australia
关键词
D O I
10.1080/02841860802495362
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:619 / 621
页数:3
相关论文
共 6 条
[1]  
Bedano PM, 2008, J CLIN ONCOL S, V26
[2]   Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus [J].
Cimpean, Anca Maria ;
Raica, Marius ;
Encica, Svetlana ;
Cornea, Remus ;
Bocan, Viorica .
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER, 2008, 190 (03) :238-245
[3]  
Fiedler WM, 2007, J CLIN ONCOL, V25
[4]  
ISAMBERT N, 2008, J CLIN ONCOL S, V26
[5]  
Rosen LS, 2007, J CLIN ONCOL, V25, P2369, DOI 10.1200/JCO.2006.07.8170
[6]   Motesanib diphosphate in progressive differentiated thyroid cancer [J].
Sherman, Steven I. ;
Wirth, Lori J. ;
Droz, Jean-Pierre ;
Hofmann, Michael ;
Bastholt, Lars ;
Martins, Renato G. ;
Licitra, Lisa ;
Eschenberg, Michael J. ;
Sun, Yu-Nien ;
Juan, Todd ;
Stepan, Daniel E. ;
Schlumberger, Martin J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (01) :31-42